Literature DB >> 20422346

Effect of radiation treatment on newly established human breast cancer cell lines MACL-1 and MGSO-3.

Caryne Margotto Bertollo1, Cristiane Rodrigues Correa, Dawidson Assis Gomes, Elaine Maria Souza-Fagundes, Alfredo Miranda Goes.   

Abstract

The characterization of new cell lines is an important tool to understand the biological processes involved in cancer treatments. In the present study, we used two newly established epithelial human breast cancer cell lines from primary sites MACL-1 and MGSO-3 and compared their susceptibility to the treatment with ionizing radiation (IR) with the commercial cell line MDA-MB-231. In the doses used (10 or 20 Gy), IR induced a reduction in cell viability and cell death, measured as DNA fragmentation, at 48 and 72 h after treatment. In addition, 48 h after treatment with IR, we observed an enhancement in the percentage of apoptotic cells. The broad-range caspases inhibitor zVAD-FMK inhibited cytotoxicity induced by IR. After 24 h, treatment with IR activated caspase-9 in MACL-1 and MDA-MB-231 but not in MGSO-3 cells. Thirty hours after treatment with IR (20 Gy), we observed an activation of caspases 8 and 3. These results suggest the involvement of caspases in the cell death induced by IR in two newly established cell lines. These cells may be useful in studies of breast cancer in defining basic mechanisms in molecular and cellular radiobiology and may contribute to the rational design of future models of cancer therapies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20422346     DOI: 10.1007/s13277-010-0029-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  29 in total

Review 1.  How does radiation kill cells?

Authors:  E C Jonathan; E J Bernhard; W G McKenna
Journal:  Curr Opin Chem Biol       Date:  1999-02       Impact factor: 8.822

Review 2.  Regulation of cell death: the calcium-apoptosis link.

Authors:  Sten Orrenius; Boris Zhivotovsky; Pierluigi Nicotera
Journal:  Nat Rev Mol Cell Biol       Date:  2003-07       Impact factor: 94.444

3.  Clonogenic assay of cells in vitro.

Authors:  Nicolaas A P Franken; Hans M Rodermond; Jan Stap; Jaap Haveman; Chris van Bree
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

4.  Mathematical model of a network of interaction between p53 and Bcl-2 during genotoxic-induced apoptosis.

Authors:  Yasam Dogu; José Díaz
Journal:  Biophys Chem       Date:  2009-04-05       Impact factor: 2.352

5.  Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.

Authors:  Joseph Ragaz; Ivo A Olivotto; John J Spinelli; Norman Phillips; Stewart M Jackson; Kenneth S Wilson; Margaret A Knowling; Christopher M L Coppin; Lorna Weir; Karen Gelmon; Nhu Le; Ralph Durand; Andrew J Coldman; Mohamed Manji
Journal:  J Natl Cancer Inst       Date:  2005-01-19       Impact factor: 13.506

Review 6.  Radioresistance in carcinoma of the breast.

Authors:  J K A Jameel; V S R Rao; L Cawkwell; P J Drew
Journal:  Breast       Date:  2004-12       Impact factor: 4.380

7.  Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells.

Authors:  S Mandlekar; R Yu; T H Tan; A N Kong
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

8.  DNA damage induces two distinct modes of cell death in ovarian carcinomas.

Authors:  H Vakifahmetoglu; M Olsson; C Tamm; N Heidari; S Orrenius; B Zhivotovsky
Journal:  Cell Death Differ       Date:  2007-12-07       Impact factor: 15.828

Review 9.  Relevance of breast cancer cell lines as models for breast tumours: an update.

Authors:  Marc Lacroix; Guy Leclercq
Journal:  Breast Cancer Res Treat       Date:  2004-02       Impact factor: 4.872

Review 10.  Breast cancer cell lines: friend or foe?

Authors:  Sarah E Burdall; Andrew M Hanby; Mark R J Lansdown; Valerie Speirs
Journal:  Breast Cancer Res       Date:  2003-02-03       Impact factor: 6.466

View more
  2 in total

1.  Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole.

Authors:  Akhilesh Rawat; Gopisetty Gopal; Ganesharaja Selvaluxmy; Thangarajan Rajkumar
Journal:  Cell Oncol (Dordr)       Date:  2013-09-27       Impact factor: 6.730

2.  Genomic and phenotypic profiles of two Brazilian breast cancer cell lines derived from primary human tumors.

Authors:  Natássia C R Corrêa; Hellen Kuasne; Jerusa A Q A Faria; Ciça C S Seixas; Iria G D Santos; Francine B Abreu; Suely Nonogaki; Rafael M Rocha; Gerluza Aparecida Borges Silva; Helenice Gobbi; Silvia R Rogatto; Alfredo M Goes; Dawidson A Gomes
Journal:  Oncol Rep       Date:  2013-02-12       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.